Clinical Trials Directory

Trials / Unknown

UnknownNCT00914030

Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders

Visual Exploration and Attention : Studies in Patients With Schizophrenia and Autism Spectrum Disorders

Status
Unknown
Phase
Study type
Observational
Enrollment
140 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
7 Years – 55 Years
Healthy volunteers
Accepted

Summary

The aim of the protocol is to better understand the impairments in visual processing, as such impairments may induce social interaction difficulties in subjects with autism spectrum disorders (adults and children) and schizophrenia, like face exploration.The same protocol will be used for the three populations, each population being compared with matched controls. The explorations are designed to test two different hypotheses regarding the mechanisms of the visual perception difficulties of the two populations. Even though difficulties to extract the global form of objects have been described in both subjects with autism and schizophrenia, we will test two different hypotheses for the two populations. We will test the hypothesis that subjects with autism display an advantage for the processing of local information arising at an early level of processing, whereas disorders observed in patients with schizophrenia originate from attention disorders. The protocol includes three consecutive studies, each one being applied in each of the three populations.

Conditions

Interventions

TypeNameDescription
OTHERNeuropsychological evaluationStudy one: global/local processing, with a neutral prime (stimulus influencing the processing of the subsequent stimulus)Study two: global/ local processing with a prime whose elements are collinear.Study three: global/local processing with a prime whose elements are not collinear

Timeline

Start date
2009-06-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2009-06-04
Last updated
2016-08-26

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT00914030. Inclusion in this directory is not an endorsement.